IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.
复制标题
DOI:
10.1084/jem.20090207
复制
发表时间:
2009-07-06
期刊:
影响因子:
--
通讯作者:
Yu H
中科院分区:
文献类型:
--
作者:
Wang L;Yi T;Kortylewski M;Pardoll DM;Zeng D;Yu H
Although the Th17 subset and its signature cytokine, interleukin (IL)-17A (IL-17), are implicated in certain autoimmune diseases, their role in cancer remains to be further explored. IL-17 has been shown to be elevated in several types of cancer, but how it might contribute to tumor growth is still unclear. We show that growth of B16 melanoma and MB49 bladder carcinoma is reduced in IL-17−/− mice but drastically accelerated in IFN-γ−/− mice, contributed to by elevated intratumoral IL-17, indicating a role of IL-17 in promoting tumor growth. Adoptive transfer studies and analysis of the tumor microenvironment suggest that CD4+ T cells are the predominant source of IL-17. Enhancement of tumor growth by IL-17 involves direct effects on tumor cells and tumor-associated stromal cells, which bear IL-17 receptors. IL-17 induces IL-6 production, which in turn activates oncogenic signal transducer and activator of transcription (Stat) 3, up-regulating prosurvival and proangiogenic genes. The Th17 response can thus promote tumor growth, in part via an IL-6–Stat3 pathway.
登录
查看更多内容
影响因子:
11.5
作者:
Sfanos, Karen Sandell;Bruno, Tullia C.;Drake, Charles G.
通讯作者:
Drake, Charles G.
DOI:
10.1073/pnas.0600666103
发表时间:
2006-05-23
影响因子:
11.1
作者:
Chen, Zhi;Laurence, Arian;O'Shea, John J.
通讯作者:
O'Shea, John J.
影响因子:
50.3
作者:
Kortylewski M;Xin H;Kujawski M;Lee H;Liu Y;Harris T;Drake C;Pardoll D;Yu H
通讯作者:
Yu H
DOI:
10.1073/pnas.0710686105
发表时间:
2008-10-07
影响因子:
11.1
作者:
Miyahara, Yoshihiro;Odunsi, Kunle;Wang, Rong-Fu
通讯作者:
Wang, Rong-Fu
DOI:
10.1109/access.2023.3293001
发表时间:
--
期刊:
IEEE Access
影响因子:
3.6
作者:
Yi-Ming Tseng; Bang-Ren Chen; Wei-Cheng Lin; Wen-Jay Lee; Nan-Yow Chen; Tian-Li Wu
通讯作者:
Yi-Ming Tseng